Bone and Joint Diseases

Researchers at TRI are investigating bone and joint diseases including rheumatoid arthritis, ankylosing spondylitis and osteoarthritis. 

Rheumatoid Arthritis 

UQ Professor Ranjeny Thomas and her team have developed a vaccine therapy currently undergoing clinical trials for rheumatoid arthritis. The therapy could potentially assist with treatments for other autoimmune diseases such as type 1 diabetes and multiple sclerosis. the study of autoimmune disease and restoration of tolerance.Professor Thomas is founder and a director of the spin-off company based at TRI, Dendright, which is developing vaccines to suppress autoimmune diseases.

Ankylosing Spondylitis

A world leader in genetics and functional genomics, Professor Matt Brown has identified over a hundred genes involved in common diseases including ankylosing spondylitis, osteoporosis and rheumatoid arthritis, amongst other diseases. Prof Brown and his team have developed DNA sequencing methodology to identify mutations causing single gene diseases, and using this have identified several new mutations causing human skeletal disorders which affect approximately 1% of Australians.


UQ's Dr John Kemp and Professor David Evans are working on a project to identify drug targets for patients with osteoporosis. They have recently published more than 500 genetic markers which determine bone mineral density, one of the strongest risk factors for osteoporosis. It is hoped that this 'atlas' of genetic markers may lead to development of treatments to improve bone density and reduce risk of fracture. Read more

Mater's Associate Professor Allison Pettit is currently working on on new and improved strategies to maintain peak bone health, rebuild fragile skeletons and/or reduce the impact of fracture in patients with osteoporosis or osteopenia. Read more

Related News

Key Researchers
Emma Letitia Duncan
Gethin Penar Thomas
Matthew Arthur Brown
Tony Kenna
Allison Pettit
Ranjeny Thomas
Show More ...
Over $5.9 million in NHMRC funding awarded to TRI-based researchers for 2019 In the latest round of NHMRC funding announced this month, TRI-based researchers from UQ, QUT and Mater-UQ have secured...Read more
Early bird registration open for APLAR-ARA 2019 Are you working in research areas relevant to rheumatology such as pain, autoimmune diseases, bone and joint diseases, inflammation, and immunology? Do...Read more
Arthritis Qld - 18th Annual Health Professionals Seminar Join Arthritis Qld at the 18th Annual Health Professionals Seminar to be held at the TRI on the 10th March. Tickets*: Early bird - $160 (...Read more